Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Inflammatory Bowel Diseases

  Free Subscription


19.05.2025

1 Aliment Pharmacol Ther
3 BMC Gastroenterol
2 Clin Gastroenterol Hepatol
1 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
2 Gut
10 Inflamm Bowel Dis
1 J Clin Gastroenterol
5 J Crohns Colitis
1 J Gastroenterol
3 Lancet Gastroenterol Hepatol
2 PLoS One
1 Scand J Gastroenterol
1 Z Gastroenterol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. IRSHAD M, Irshad S
    Letter: Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next-Generation Sequencing.
    Aliment Pharmacol Ther. 2025 May 9. doi: 10.1111/apt.70152.
    PubMed        


    BMC Gastroenterol

  2. TAKEI K, Inokuchi T, Hiraoka S, Ishiguro M, et al
    Efficient diagnosis for endoscopic remission in Crohn's diseases by the combination of three non-invasive markers.
    BMC Gastroenterol. 2025;25:364.
    PubMed         Abstract available

  3. WONG C, Bassett P, Kamperidis N, Misra R, et al
    Prolonged time to treatment of biologics in inflammatory bowel disease: disparities from a retrospective study in a tertiary referral centre in the UK.
    BMC Gastroenterol. 2025;25:352.
    PubMed         Abstract available

  4. DUAN R, Mei W, Lei M, Chen D, et al
    Care needs profiles of Crohn's disease patients and their associations with symptom clusters, post-traumatic growth, and family function: a latent profile analysis.
    BMC Gastroenterol. 2025;25:351.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  5. D'AMICO F, Peyrin-Biroulet L, Danese S
    Concomitant medications and advanced therapies in ulcerative colitis: patient-centric approach for optimal disease control.
    Clin Gastroenterol Hepatol. 2025 May 8:S1542-3565(25)00336.
    PubMed        

  6. HONAP S, Patel K, Peyrin-Biroulet L
    Acute Severe Ulcerative Colitis Clinical Trial Design - Author's Reply.
    Clin Gastroenterol Hepatol. 2025 May 10:S1542-3565(25)00361.
    PubMed        


    Dig Dis Sci

  7. LIU GXH, Day AS
    Alpha Fail: Ustekinumab to the Rescue After TNFalpha Failure in Patients with Moderate to Severe Crohn's Disease.
    Dig Dis Sci. 2025 May 10. doi: 10.1007/s10620-025-09090.
    PubMed        


    Eur J Gastroenterol Hepatol

  8. GATT Y, Chatlani D, Camilleri C, Sciberras M, et al
    The role of chest X-ray in detecting latent tuberculosis among patients with low-risk inflammatory bowel disease before advanced therapy.
    Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002975.
    PubMed         Abstract available

  9. SZLAK J, Magdziak A, Mroz A, Wieszczy-Szczepanik P, et al
    Cytomegalovirus infection in patients with active ulcerative colitis: a prospective observational study.
    Eur J Gastroenterol Hepatol. 2025 May 12. doi: 10.1097/MEG.0000000000003001.
    PubMed         Abstract available

  10. COLWILL M, Baillie S, Radia C, White S, et al
    The impact of ethnicity on delays in initiating advanced therapy for inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2025 Apr 30. doi: 10.1097/MEG.0000000000002995.
    PubMed         Abstract available


    Gut

  11. BLACKWELL J, Plevris N, Bancil A, Kobayashi T, et al
    Withdrawal of antitumour necrosis factor in patients with inflammatory bowel disease in remission: a randomised placebo-controlled clinical trial of GETECCU.
    Gut. 2025 May 13:gutjnl-2025-334946. doi: 10.1136/gutjnl-2025-334946.
    PubMed        

  12. PAL P, Mateen MA, Sekaran A, Pooja K, et al
    Can transperineal ultrasound replace endoscopic ultrasound in staging distal ulcerative colitis?
    Gut. 2025 May 13:gutjnl-2025-335681. doi: 10.1136/gutjnl-2025-335681.
    PubMed        


    Inflamm Bowel Dis

  13. SILA S, Aloi M, Cucinotta U, Gianolio L, et al
    Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD.
    Inflamm Bowel Dis. 2025;31:1263-1271.
    PubMed         Abstract available

  14. MASSIRONI S, Pigoni A, Vegni EAM, Keefer L, et al
    The Burden of Psychiatric Manifestations in Inflammatory Bowel Diseases: A Systematic Review With Meta-analysis.
    Inflamm Bowel Dis. 2025;31:1441-1459.
    PubMed         Abstract available

  15. MUNASINGHE S, Chandrakasan S
    Maternal Microchimerism, a Red Flag or a Red Herring in Very-Early-Onset Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2025 May 9:izaf070. doi: 10.1093.
    PubMed        

  16. GOZDZIK M, Unninayar D, Siegal DM, Sarker AK, et al
    Risk Factors for Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis by Phase of Care.
    Inflamm Bowel Dis. 2025 May 9:izaf078. doi: 10.1093.
    PubMed         Abstract available

  17. KOKKOTIS G, Bamias G
    Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 May 9:izaf105. doi: 10.1093.
    PubMed        

  18. PRENTICE RE, Cho SX, Bell SJ, Nold-Petry CA, et al
    Innate and Adaptive Immunity is not Impacted by Inflammatory Bowel Disease Medications in Pregnant Women and Their Offspring.
    Inflamm Bowel Dis. 2025 May 9:izaf052. doi: 10.1093.
    PubMed         Abstract available

  19. PIROLLI NH, Raufman JP, Jay SM
    Therapeutic Potential and Translational Challenges for Bacterial Extracellular Vesicles in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2025 May 13:izaf107. doi: 10.1093.
    PubMed         Abstract available

  20. STRATIL AS, Friedrich B, Brunner P, Rath S, et al
    Six-Year Observation Data Reveal Reduction in Concomitant Steroid Overuse for Inflammatory Bowel Disease in Germany.
    Inflamm Bowel Dis. 2025 May 13:izaf108. doi: 10.1093.
    PubMed         Abstract available

  21. AOYAMA K, Yamamura R, Katsurada T, Shimizu T, et al
    Decreased Fecal Nicotinamide and Increased Bacterial Nicotinamidase Gene Expression in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2025 May 13:izaf092. doi: 10.1093.
    PubMed         Abstract available

  22. WANG H, Chen Y, He J, Luo Z, et al
    Biological Ageing and the Risk of Inflammatory Bowel Disease: Exploring the Role of Lifestyle and Genetic Susceptibility in a Nationwide Prospective Study.
    Inflamm Bowel Dis. 2025 May 13:izaf106. doi: 10.1093.
    PubMed         Abstract available


    J Clin Gastroenterol

  23. SINGH AK, Shukla S, Acharya R, Birda CL, et al
    Impact of Clostridioides difficile Infection on the Outcome of Severe Flare of Ulcerative Colitis.
    J Clin Gastroenterol. 2025 May 12. doi: 10.1097/MCG.0000000000002196.
    PubMed         Abstract available


    J Crohns Colitis

  24. SALOMON B, Sudhakar P, Bergemalm D, Andersson E, et al
    Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study.
    J Crohns Colitis. 2025;19:jjae169.
    PubMed         Abstract available

  25. YU M, Si C, Xinjue H, Pan Y, et al
    Biglycan deficiency alleviates intestinal fibrosis through BMP-7-mediated Smad1/5/8 signaling.
    J Crohns Colitis. 2025;19:jjaf065.
    PubMed         Abstract available

  26. D'HAENS G, Danese S, Panaccione R, Rubin DT, et al
    Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis.
    J Crohns Colitis. 2025 May 13:jjaf080. doi: 10.1093.
    PubMed         Abstract available

  27. KONTOLA K, Ilus T, Huhtala H, Helavirta L, et al
    Risk of colectomy is decreasing among newly diagnosed Finnish ulcerative colitis patients.
    J Crohns Colitis. 2025 May 13:jjaf081. doi: 10.1093.
    PubMed         Abstract available


  28. Correction to: Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.
    J Crohns Colitis. 2025;19:jjaf071.
    PubMed        


    J Gastroenterol

  29. SAWAHASHI M, Kakuta Y, Naito T, Okazaki S, et al
    Autoantibodies against endothelial protein C receptor and integrin alphavbeta6 predict the development of ulcerative colitis.
    J Gastroenterol. 2025 May 15. doi: 10.1007/s00535-025-02263.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  30. PANACCIONE R, Vermeire S, Danese S, Higgins PDR, et al
    Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study.
    Lancet Gastroenterol Hepatol. 2025;10:507-519.
    PubMed         Abstract available

  31. NOOR NM, Parkes M, Raine T
    U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis.
    Lancet Gastroenterol Hepatol. 2025;10:492-493.
    PubMed        

  32. NEURATH MF, Artis D, Becker C
    The intestinal barrier: a pivotal role in health, inflammation, and cancer.
    Lancet Gastroenterol Hepatol. 2025;10:573-592.
    PubMed         Abstract available


    PLoS One


  33. Correction: Development of a novel complex inflammatory bowel disease mouse model: Reproducing human inflammatory bowel disease etiologies in mice.
    PLoS One. 2025;20:e0324178.
    PubMed         Abstract available

  34. GHYSELINCK J, Verstrepen L, Rakebrandt M, Marynissen S, et al
    In vitro fermentation of yeast cell walls (mannan-oligosaccharide) and purified beta-glucans modulates the colonic microbiota of dogs with inflammatory bowel disease and demonstrates protective effects on barrier integrity and anti-inflammatory proper
    PLoS One. 2025;20:e0322877.
    PubMed         Abstract available


    Scand J Gastroenterol

  35. DHARMADASA V, Yip Lundstrom LM, Khatibi N, Hossain J, et al
    Factors affecting response rates in patient-reported outcome measures in inflammatory bowel disease.
    Scand J Gastroenterol. 2025 May 10:1-14. doi: 10.1080/00365521.2025.2501070.
    PubMed         Abstract available


    Z Gastroenterol

  36. PUESCHEL L, Hupa-Breier K, Wedemeyer H, Lenzen H, et al
    Food-related Quality of Life in patients with Inflammatory Bowel Disease: Translation and Validation of the German version of FR-QoL-29.
    Z Gastroenterol. 2025;63:477-485.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.